Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CDK4 5件: PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
2 CDK6 3件: PI3K-Akt signaling pathway, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
3 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
4 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
5 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
6 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00397 Tropicamide 1件: 6
7 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
8 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
9 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
10 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
11 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
12 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
13 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
14 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00397 Tropicamide 1件: 6
15 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
16 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00525 Pilocarpine 3件: 6, 53, 299
17 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D07226 Fesoterodine 1件: 6
18 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
19 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
20 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
21 CSF1R 5件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
22 CSF1R 5件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
23 CSF3R 1件: PI3K-Akt signaling pathway D03235 Filgrastim 35件: 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331
24 CSF3R 1件: PI3K-Akt signaling pathway D03247 Lenograstim 7件: 2, 13, 16, 18, 19, 57, 65
25 CSF3R 1件: PI3K-Akt signaling pathway D06889 Pegfilgrastim 1件: 60
26 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D01977 Gefitinib 1件: 75
27 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D03455 Cetuximab 2件: 51, 86
28 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D07907 Erlotinib 1件: 94
29 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D08108 Lapatinib 3件: 34, 74, 75
30 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D08950 Neratinib 1件: 34
31 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D11251 Icotinib 1件: 34
32 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D11772 Tesevatinib 1件: 67
33 EPHA2 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03658 Dasatinib 2件: 51, 85
34 EPHA2 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06414 Dasatinib 2件: 51, 85
35 EPOR 1件: PI3K-Akt signaling pathway D09946 Peginesatide 1件: 283
36 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D08108 Lapatinib 3件: 34, 74, 75
37 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D08950 Neratinib 1件: 34
38 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D11772 Tesevatinib 1件: 67
39 ERBB4 2件: PI3K-Akt signaling pathway, Proteoglycans in cancer D08950 Neratinib 1件: 34
40 FGFR1 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
41 FGFR1 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer D11589 Infigratinib 1件: 276
42 FGFR3 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
43 FGFR3 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib 1件: 276
44 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D05338 Palifermin 5件: 13, 36, 38, 39, 65
45 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
46 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D11589 Infigratinib 1件: 276
47 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D03218 Axitinib 1件: 34
48 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08552 Sunitinib 2件: 28, 34
49 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08881 Cediranib 1件: 34
50 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D10481 Nintedanib 5件: 51, 85, 89, 227, 228
51 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D08524 Sorafenib 2件: 34, 86
52 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
53 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
54 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03218 Axitinib 1件: 34
55 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08524 Sorafenib 2件: 34, 86
56 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08552 Sunitinib 2件: 28, 34
57 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08881 Cediranib 1件: 34
58 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D10481 Nintedanib 5件: 51, 85, 89, 227, 228
59 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D11772 Tesevatinib 1件: 67
60 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D00753 Sirolimus 40件: 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331
61 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D02714 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277
62 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D06068 Temsirolimus 1件: 13
63 GHR 1件: PI3K-Akt signaling pathway D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
64 GHR 1件: PI3K-Akt signaling pathway D05394 Pegvisomant 2件: 78, 265
65 GHR 1件: PI3K-Akt signaling pathway D11193 Somavaratan 1件: 78
66 GHR 1件: PI3K-Akt signaling pathway D11194 Somapacitan 2件: 78, 195
67 GHR 1件: PI3K-Akt signaling pathway D11486 Lonapegsomatropin 1件: 78
68 IFNA1 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
69 IFNA1 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
70 IFNA2 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
71 IFNA2 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
72 IFNA4 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
73 IFNA4 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
74 IFNA5 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
75 IFNA5 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
76 IFNA6 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
77 IFNA6 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
78 IFNA7 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
79 IFNA7 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
80 IFNA8 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
81 IFNA8 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
82 IFNA10 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
83 IFNA10 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
84 IFNA13 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
85 IFNA13 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
86 IFNA14 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
87 IFNA14 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
88 IFNA16 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
89 IFNA16 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
90 IFNA17 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
91 IFNA17 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
92 IFNA21 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
93 IFNA21 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
94 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00745 Interferon alfa-2a 1件: 56
95 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00746 Interferon beta-1b 1件: 13
96 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D02745 Interferon alfa-2b 2件: 25, 34
97 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
98 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D04554 Interferon beta-1a 4件: 13, 26, 96, 97
99 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D10483 Peginterferon beta-1a 1件: 13
100 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D11082 Anifrolumab 3件: 46, 49, 53
101 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00745 Interferon alfa-2a 1件: 56
102 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00746 Interferon beta-1b 1件: 13
103 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D02745 Interferon alfa-2b 2件: 25, 34
104 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
105 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D04554 Interferon beta-1a 4件: 13, 26, 96, 97
106 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D10483 Peginterferon beta-1a 1件: 13
107 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D11082 Anifrolumab 3件: 46, 49, 53
108 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
109 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09680 Teprotumumab 1件: 51
110 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09925 Linsitinib 1件: 232
111 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
112 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D03058 Basiliximab 6件: 2, 50, 66, 97, 222, 228
113 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D03639 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284
114 IL2RB 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
115 IL2RG 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Primary immunodeficiency D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
116 IL4 4件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway D03117 Binetrakin 1件: 46
117 IL4R 3件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D10354 Dupilumab 5件: 51, 97, 98, 160, 162
118 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
119 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D08976 Pomalidomide 5件: 28, 51, 85, 227, 331
120 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D09669 Siltuximab 2件: 28, 331
121 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D10080 Sirukumab 2件: 41, 46
122 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D12487 Olokizumab 2件: 46, 96
123 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D02596 Tocilizumab 21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
124 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D10161 Sarilumab 5件: 41, 46, 84, 107, 271
125 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D11079 Satralizumab 3件: 11, 13, 86
126 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03230 Insulin human 2件: 96, 156
127 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03250 Insulin glargine 1件: 299
128 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D04539 Insulin detemir 1件: 299
129 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D06590 Firategrast 1件: 13
130 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D06886 Natalizumab 6件: 13, 15, 25, 46, 63, 96
131 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D08083 Vedolizumab 3件: 94, 96, 97
132 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D10540 Abrilumab 2件: 96, 97
133 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D08083 Vedolizumab 3件: 94, 96, 97
134 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D09901 Etrolizumab 2件: 96, 97
135 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D10540 Abrilumab 2件: 96, 97
136 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib 3件: 60, 65, 228
137 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
138 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
139 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib 1件: 46
140 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
141 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib 4件: 46, 51, 97, 228
142 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
143 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D11400 Abrocitinib 1件: 84
144 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib 3件: 60, 65, 228
145 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
146 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
147 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D10653 Peficitinib 1件: 46
148 JAK3 6件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
149 JAK3 6件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency D10653 Peficitinib 1件: 46
150 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D03218 Axitinib 1件: 34
151 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08524 Sorafenib 2件: 34, 86
152 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08552 Sunitinib 2件: 28, 34
153 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08881 Cediranib 1件: 34
154 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D10062 Cabozantinib 1件: 34
155 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
156 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D11772 Tesevatinib 1件: 67
157 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03658 Dasatinib 2件: 51, 85
158 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06414 Dasatinib 2件: 51, 85
159 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
160 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08524 Sorafenib 2件: 34, 86
161 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08552 Sunitinib 2件: 28, 34
162 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08953 Nilotinib 5件: 6, 8, 34, 51, 86
163 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D10229 Masitinib 6件: 2, 5, 6, 13, 46, 96
164 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D11270 Pexidartinib 1件: 34
165 MET 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Proteoglycans in cancer, Renal cell carcinoma D10062 Cabozantinib 1件: 34
166 NFKB1 20件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer D01146 Iguratimod 5件: 46, 51, 53, 271, 300
167 NGF 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D09387 Tanezumab 2件: 226, 298
168 NGFR 5件: Virion - Lyssavirus, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11028 Cenegermin 2件: 53, 90
169 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
170 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08552 Sunitinib 2件: 28, 34
171 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
172 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
173 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D03658 Dasatinib 2件: 51, 85
174 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D06414 Dasatinib 2件: 51, 85
175 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08524 Sorafenib 2件: 34, 86
176 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08552 Sunitinib 2件: 28, 34
177 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
178 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
179 PGF 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D09574 Aflibercept 2件: 90, 166
180 PIK3CA 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11011 Alpelisib 1件: 138
181 PIK3CA 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
182 PIK3CB 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
183 PIK3CD 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
184 PIK3CD 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11437 Parsaclisib 3件: 35, 53, 61
185 PRKAA1 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D04966 Metformin 25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
186 PRKAA2 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D04966 Metformin 25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
187 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D09666 Selumetinib 1件: 34
188 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
189 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10405 Cobimetinib 1件: 280
190 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10604 Binimetinib 1件: 34
191 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D11675 Mirdametinib 1件: 34
192 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D09666 Selumetinib 1件: 34
193 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
194 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10405 Cobimetinib 1件: 280
195 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10604 Binimetinib 1件: 34
196 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D11675 Mirdametinib 1件: 34
197 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D00987 Cabergoline 3件: 6, 74, 75
198 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D01348 Terguride 2件: 51, 86
199 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D03165 Bromocriptine 2件: 6, 74
200 RAF1 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer D08524 Sorafenib 2件: 34, 86
201 BCL2 10件: Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer D10679 Venetoclax 1件: 28
202 RELA 20件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer D12181 Edasalonexent 1件: 113
203 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02754 Acitretin 1件: 37
204 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
205 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D03106 Bexarotene 2件: 13, 75
206 SYK 4件: PI3K-Akt signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis D09347 Fostamatinib 4件: 46, 49, 61, 66
207 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D05697 Ranibizumab 4件: 34, 166, 227, 301
208 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D06409 Bevacizumab 6件: 13, 34, 85, 87, 227, 280
209 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D09574 Aflibercept 2件: 90, 166
210 VEGFB 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Relaxin signaling pathway D09574 Aflibercept 2件: 90, 166
211 VWF 2件: PI3K-Akt signaling pathway, Platelet activation D11160 Caplacizumab 1件: 64
212 FGF23 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D10913 Burosumab 1件: 238
213 CASP9 10件: Platinum drug resistance, PI3K-Akt signaling pathway, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer, Viral myocarditis D11195 Rimiducid 6件: 19, 60, 65, 284, 285, 326
214 CD19 2件: PI3K-Akt signaling pathway, Primary immunodeficiency D11496 Obexelimab 1件: 300
215 CD19 2件: PI3K-Akt signaling pathway, Primary immunodeficiency D11757 Inebilizumab 4件: 11, 13, 51, 300